Clinical Evaluation of Two Daily Disposable Lenses in Neophytes
This study has been completed.
Sponsor:
CIBA VISION
Information provided by (Responsible Party):
Alcon Research ( CIBA VISION )
ClinicalTrials.gov Identifier:
NCT00987623
First received: September 29, 2009
Last updated: June 26, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the performance of two daily disposable contact lenses in a population of neophytes (new wearers).
| Condition | Intervention |
|---|---|
|
Myopia |
Device: nelfilcon A contact lens Device: narafilcon A contact lens |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Clinical Evaluation of Two Daily Disposable Lenses in Neophytes |
Resource links provided by NLM:
Further study details as provided by Alcon Research:
Primary Outcome Measures:
- Overall Lens Satisfaction [ Time Frame: 1 week ] [ Designated as safety issue: No ]Overall Lens Satisfaction, as interpreted by the participant and reported on a questionnaire as a single, retrospective evaluation of 1-week's wear time. Overall lens satisfaction was measured on a 10-point scale, with 1 being Poor and 10 being Excellent
| Enrollment: | 326 |
| Study Start Date: | August 2009 |
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: nelfilcon A
Commercially marketed contact lens worn in both eyes on a daily wear, daily disposable basis for one week.
|
Device: nelfilcon A contact lens
Commercially marketed, hydrogel, single-vision contact lens for daily wear, daily disposable use.
|
|
Active Comparator: narafilcon A
Commercially marketed contact lens worn in both eyes on a daily wear, daily disposable basis for one week.
|
Device: narafilcon A contact lens
Commercially marketed, silicone hydrogel, single-vision contact lens for daily wear, daily disposable use.
|
Eligibility| Ages Eligible for Study: | up to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- No previous contact lens experience or attempts to try contact lenses (neophytes).
- Currently wearing spectacles or needing vision correction in both eyes.
- No older than 45 years of age.
- Able to achieve visual acuity of at least 20/40 in each eye with study lenses in the available parameters.
- Interested in wearing contact lenses.
- Willing to wear study lenses for at least 8 hours/day, at least 5 days/week.
- Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion Criteria:
- Eye injury or surgery within twelve weeks prior to enrollment.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Previous corneal or refractive surgery.
- Currently enrolled in any Clinical Trial.
- Other protocol-defined inclusion/exclusion criteria may apply.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Alcon Research ( CIBA VISION ) |
| ClinicalTrials.gov Identifier: | NCT00987623 History of Changes |
| Other Study ID Numbers: | P-337-C-031 |
| Study First Received: | September 29, 2009 |
| Results First Received: | December 17, 2010 |
| Last Updated: | June 26, 2012 |
| Health Authority: | Germany: Ethics Commission |
Additional relevant MeSH terms:
|
Myopia Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on June 18, 2013